Biologics Market Growth CAGR 6.9% During 2023-2032 | Xcellent Insights

Growing demand for personalized medicine is a key factor expected to drive global market growth during the forecast period.

Pune, Jan. 03, 2024 (GLOBE NEWSWIRE) -- The global biologics market is expected to register a rapid revenue CAGR of 6.9% during the forecast period. This growth can be attributed to factors such rising number of product launches, high prevalence of various types of chronic diseases, and increasing adoption of biologic drugs.

Biologics are a class of therapeutic drugs derived from living organisms such as animals, microorganisms, and human cells. These are large, complex molecules including proteins, antibodies, or nucleic acids that help in targeting specific molecules involved in disease processes.

Biologics have high specificity and their complex nature makes them a powerful tool for treating many types of autoimmune diseases, cancer, infectious diseases, and genetic disorders. These biologics encompass a wide range of products such as monoclonal antibodies, hormones, enzymes, and vaccines and are preferred due to longer half-life allowing for less frequent dosing and better patient compliance.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @

Factors such as rapid advancements in biotechnology, patent expirations, favorable support from regulatory agencies such as the FDA and EMA, and rising investments by pharmaceutical and biotechnology companies in R&D for biologics are expected to boost global market growth over the forecast period.

However, factors such as high production and manufacturing costs, time-consuming and rigorous regulatory challenges, and concerns regarding immunogenicity are expected to hamper overall market growth during the forecast period.

Some Key Highlights from the Report:

  • Based on manufacturing, the outsourced segment is expected to register robust revenue CAGR over the forecast period. This can be attributed to rising number of companies providing outsourcing services, high preference for outsourcing due to high initial investments required for setting up and maintaining a biological manufacturing facility, enhanced flexibility, scalability, and access to expertise through outsourcing.
  • North America is expected to account for the largest revenue share during the forecast period owing to rising prevalence of different complex chronic diseases, presence of well-established healthcare and pharmaceutical facilities and infrastructure and leading companies, and rising investments in R&D projects to develop targeted drugs.

Xcellent Insights is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @

  • Novartis AG., AstraZeneca PLC., Bayer AG., Sanofi SA., Pfizer Inc., Merck & Co., Johnson and Johnson, GlaxoSmithKline PLC., Amgen Inc., AbbVie Inc., F. Hoffmann-La Roche AG., Eli Lilly and Company., and AGC Biologics are some of the leading companies operating in the global biologics market.
  • In October 2023, ATCC and US Pharmacopeia announced the launch of the first joint products to reduce the risks and enhance the quality of biological therapeutics and vaccines.

Report Coverage:

Report DetailsOutcome
Base Year for Estimation2022
Historical Data2018-2021
Forecast Period2023-2032
Segments Covered:Source Type, Product, Manufacturing, Disease and Region
By Source TypeMicrobial, Mammalian
By ProductMonoclonal Antibodies, Vaccines, Recombinant Proteins, Antisense & RNAi Therapeutics, Others
By ManufacturingIn-house, Outsourced
By DiseaseOncology, Infectious Diseases, Immunological Diseases, Cardiovascular Disorders, Hematological Disorders, Others
Regional ScopeNorth America, Europe, Asia Pacific, Latin America, Middle East and Africa
Country ScopeUnited States, Canada, Germany, France, UK, Italy, Russia, China, Japan, South Korea, Southeast Asia, India, Mexico, Brazil, Saudi Arabia, UAE, Turkey
Qualitative Info
  • Value Chain Analysis
  • Pricing Analysis
  • Regional Outlook
  • Market Trends
  • Market Share Analysis
  • Competition Analysis
  • Technological Advancements
Key PlayersNovartis AG., AstraZeneca PLC., Bayer AG., Sanofi SA., Pfizer Inc., Merck & Co., Johnson and Johnson, GlaxoSmithKline PLC., Amgen Inc., AbbVie Inc., F. Hoffmann-La Roche AG., Eli Lilly and Company., and AGC Biologics
Customization Scope10 Hours of Free Customization and Expert Consultation

Direct Order Can Be Placed Through This Link [Exclusive Copy] @

Competitive Landscape:

The global Biologics market is extremely competitive, comprising several key regional and global players. Leading key players are focused on adopting various strategic alliances like mergers and acquisitions, partnerships, joint ventures, collaborations, and product launches to maintain their global position and enhance their product offerings. They are also focused on innovation, and scalability, adapting to evolving technology trends and consumer needs.

Some Leading Market Companies Listed in the Report:

  • Novartis AG.
  • AstraZeneca PLC.
  • Bayer AG
  • Sanofi SA.
  • Pfizer Inc.
  • Merck & Co.
  • Johnson and Johnson
  • GlaxoSmithKline PLC.
  • Amgen Inc.
  • AbbVie Inc.
  • F. Hoffmann-La Roche AG.
  • Eli Lilly and Company
  • AGC Biologics

Browse the complete Report Summary with ToC here @

The global Biologics Market has been segmented based on source type, product, manufacturing, disease, and region:

By Source Type:

  • Microbial
  • Mammalian

By Product:

  • Monoclonal Antibodies
  • Vaccines
  • Recombinant Proteins
  • Antisense & RNAi Therapeutics
  • Others

By Manufacturing:

  • In-house
  • Outsourced

By Disease:

  • Oncology
  • Infectious Diseases
  • Immunological Diseases
  • Cardiovascular Disorders
  • Hematological Disorders
  • Others

By Region:

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Nordic Countries
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Request Free Sample Report:

Related Reports:

Spine Biologics Market

Spinal Devices and Biologics Market

Veterinary Biologics Market

Subcutaneous Biologics Market

Orthopedic Biologics Market

Biologics Safety Testing Market

About Us:

Xcellent Insights is a global market research and management consulting company offering a plethora of syndicated research reports, customized research reports, consulting services, and useful insights to leading market players, investors, startups, and stakeholders. We cover niche and established markets and identify growth opportunities to help clients make informed decisions and achieve sustainable growth in their respective market domains. We excel in providing in-depth analysis and strive to cover the latest market and industry trends to offer the best services to our clients.

Contact Us:

Name: Andy M

Phone: US: +1 4086277717


Xcellent Insights | Web:

Explore Our Blogs:

Get More Reports:

Biosimilars & Follow-on-Biologics Market

Soft Tissue Biologics Market

Biologics Contract Manufacturing Market

Spinal Fusion Biologics Market

Biologics in Spine Surgery Market

Biologics Drug Discovery and Development Market

Biologics and Biosimilars Market

Medical Autologous Biologics Market

Wound Care Biologics Market

Retinal Drugs and Biologics Market

Contact Data